PDUFA in 2016 - SRPT, OPK, PGNX, ACAD. Nothing to see here people. Move along from RPRX.
Wednesday 10/21 the volume jumped from 300,000 to 3,000,000. Insider trading? Info was leaked. Contact Milberg Weiss to initiate a class action suit. Send all info you have on reg. FD violation to Milberg.
Typical briefing docs - it causes cancer, SELL; it causes heart attacks, SELL; it causes yer hair to fall out, SELL. FDA always has negative briefing docs. Get ready for bashers tomorrow from the BD release.
FDA always makes briefing docs read as bad - MNKD caused lung cancer and FDA approved it.
I agree that RPRX will get approval. Look at chart for BDSI for last 5 days and predict RPRX. $5 maybe.
Now Hillary is in the game. See BDSI. This needs approval to hold $4. BDSI approval went from $7 to $5.
NASDAQ up 112 on Friday. Who is selling RPRX at any price?
Made $$$ on FDA approvals - HZNP, MNKD, VNDA, CHTP, BCRX, KERX, and RMTI. More drugs are approved than not approved, in the last 2 years.
Shorty RIP. Every biotech I bought in the last 2 years has got FDA approval - HZNP, MNKD, VNDA, CHTP, BCRX. Shorty did you lose all yer money yet? Shorty follows his leader, the great Adam F.
Nisha Hirani - her independent research focused on the investigation of an optical mammography device through application of near infrared spectroscopy, as well as other imaging and engineering modalities for the non-invasive detection of breast cancer.
90% chance of FDA approval. You sold MNKD at $4 before FDA approval and run-up to $10.